Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies

March 19, 2021 8:00 AM

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET VANCOUVER, BC / ACCESSWIRE / March 19, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will be presenting virtually at the upcoming Zooming...

Read more

Apollo Endosurgery Announces Inducement Grant

March 19, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021. The company's board of directors granted Chas a stock option to purchase an aggregate of 848,733 shares...

Read more

Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board

March 18, 2021 9:00 AM

A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care SAN DIEGO, CA / ACCESSWIRE / March 18, 2021 / Modular Medical, Inc. (OTCQB: MODD), a development-stage company focused on making insulin delivery technology available to a greater number of people with insulin-requiring diabetes, today announced the formal establishment of...

Read more

Experion Announces Fiscal Year End and Q4 2020 Financial Reporting Release Date and Earnings Call

March 18, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash announced today that it will be reporting its fiscal year 2020 and fourth quarter financial results for the year ending November 30, 2020...

Read more

Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada

March 18, 2021 2:00 AM

Quantum Pharma Inc. is a contract facility operated by Tetra Bio-Pharma Inc Quantum Pharma Inc. receives a Notice of Compliant rated inspection OTTAWA, ON / ACCESSWIRE / March 18, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce that its contract manufacturing facility, Quantum Pharma Inc.,...

Read more

Enveric Biosciences Discusses Acquisition of Exclusive License from Diverse Biotech and Value Catalysts Moving Forward in New Video Interview on SNN Network

March 17, 2021 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / March 17, 2021 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with David Johnson, Chairman, and CEO of Enveric Biosciences (NASDAQ:ENVB), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, according to the company's website (see here: www.enveric.com). Click the...

Read more

Protean BioDiagnostics to Present at AACR 2021 Annual Meeting

March 17, 2021 10:00 AM

ORLANDO, FL / ACCESSWIRE / March 17, 2021 / Protean BioDiagnostics Inc. ("Protean"), a disruptive biotechnology company developing and commercializing novel cancer diagnostics supporting precision oncology, is pleased to announce that its below-referenced abstract has been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting, April 10-15 and May 17-21,...

Read more

Xenetic Biosciences, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

March 17, 2021 8:00 AM

Driving development of XCART™ platform and leveraging academic collaborations through preclinical development Recent clinical, regulatory and commercial advancements from licensing partners leveraging PolyXen® platform technology FRAMINGHAM, MA / ACCESSWIRE / March 17, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing...

Read more

Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results

March 16, 2021 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second quarter ended January 31, 2021. OVERVIEW The Company reported a net loss and total comprehensive loss of $2,492,000 and $2,714,000 for the three and six-month periods ended January 31,...

Read more

Dyadic to Report Fourth Quarter and Full Year 2020 Financial Results

March 16, 2021 4:00 PM

JUPITER, FL / ACCESSWIRE / March 16, 2021 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that it will report its...

Read more

Lexaria's Antiviral Drug Evaluation Program Progressing

March 16, 2021 7:00 AM

Two of the four planned studies progressing to examine DehydraTECH™ with antivirals targeting SARS-CoV-2 / COVID-19. KELOWNA, BC / ACCESSWIRE / March 16, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces extensive progress in two of the four planned antiviral drug studies in its 2021 applied research and...

Read more

CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand

March 16, 2021 7:00 AM

Successful introductory product trials result in an agreement by three major hospital chains to use the my-Cam device ESCONDIDO, CA / ACCESSWIRE / March 16, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, announces today the anticipated addition of three major hospital chains to use Remote Cardiac...

Read more

Viewpoint Molecular Targeting(TM) Establishes Strategic Manufacturing Supply Agreement with Industry-Leader, SpectronRx, to Accelerate Build-Out of Ra-224/Pb-212 Generator (VMT-a-GEN) Production Facilities

March 15, 2021 10:00 AM

- SpectronRx is a well-established CDMO with a reputation of supplying high-quality, GMP/Pharmaceutical grade isotopes without impurities that meet FDA standards for radiopharmaceuticals - - Building out VMT-𝛼-GEN isotope generator facilities and scaling of the manufacturing processes for radionuclides are integral in advancing Viewpoint's development pipeline - - Viewpoint's proprietary VMT-𝛼-GEN isotope generator enables a...

Read more

Edesa Biotech Reaches Enrollment Milestone in COVID Study

March 15, 2021 8:10 AM

TORONTO, ON / ACCESSWIRE / March 15, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it has completed enrollment of more than 50% of the patients planned for the Phase 2 portion of its ongoing Phase 2/Phase 3 clinical study evaluating the company's EB05 drug candidate as a single-dose treatment for hospitalized COVID-19 patients...

Read more

Rapid Progress in Hypertension Studies by Lexaria

March 15, 2021 7:00 AM

Five studies underway to examine DehydraTECHTM CBD for Hypertension. KELOWNA, BC / ACCESSWIRE / March 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces extensive progress in five studies focused on the performance of DehydraTECHTM CBD as a treatment for hypertension. Three human clinical trials and two...

Read more

Tetra Bio-Pharma Provides Status of Its New Drug Submission Application in Canada

March 15, 2021 2:00 AM

Reduvo™ would be Canada's only DIN for a THC-based prescription drug The addressable market is estimated to be $80M CDN by 2022 OTTAWA, ON / ACCESSWIRE / March 15, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce that the Dronabinol Soft Gel capsules New Drug Submission (NDS) file...

Read more

Molecular Partners and Novartis Announce Inclusion of COVID-19 Antiviral Candidate, ensovibep, in NIH-Sponsored ACTIV-3 Trial

March 15, 2021 2:00 AM

ACTIV-3 trial planned to investigate safety and efficacy of ensovibep in adults hospitalized with a COVID-19 diagnosis; first patient dose expected in Q2 2021 Ensovibep to be first non-antibody therapeutic assessed in ACTIV-3 Clinical trial includes an interim analysis after 300 patients Separately, a global Phase 2-3 study in adults with mild to moderate symptoms is planned to be initiated in Q2 2021 Initial Phase 1 data support...

Read more

Experion and The Valens Company Enter into Pre-Roll Manufacturing Agreement

March 11, 2021 5:00 PM

VANCOUVER, BC / ACCESSWIRE / March 11, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash, is pleased to announce that it has entered into a custom pre-roll manufacturing agreement with The Valens Company (VLNS) (VLNCF) (the...

Read more

Hillstream BioPharma Adds Leading Cancer Drug Development Executive and Features Hillstream's Quatramer-Based Ferroptosis Inducer, HSB-1216, in Two Abstracts Available for Viewing at AACR 2021 Annual Meeting

March 11, 2021 11:00 AM

Lynne A. Bui M.D., leading cancer drug development executive, joins Hillstream BioPharma's Board of Directors Abstracts highlight mechanistic and pharmacokinetic data from HSB-1216 in small cell lung cancer and in combination with ultra-low-dose chemotherapy in triple-negative breast cancer BRIDGEWATER, NJ / ACCESSWIRE / March 11, 2021 / Hillstream BioPharma, Inc. ("Hillstream") today announced that two abstracts highlighting...

Read more

ITOCO INC to Acquire Biotech Protocols and Technology Related to Carbon Credit Generation From ECAPFIN S.A.P.I. DE C.V

March 11, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / March 11, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that it has signed a purchase agreement with ECAPFIN S.A.P.I. De C.V. of Domicilio DISTRITO FEDERAL (Mexico City) Mexico, to acquire all the assets of the company which include: Bio Tech related to the growth and usage of the Nopal Cactus; Agreements to amalgamate Nopal Cactus Farms and related assets in Mexico and elsewhere for the purpose of...

Read more